An intravenously-administered agent capable of modulating the activity of epidermal growth factor receptor (EGFR), with potential antineoplastic activity.
Learn more about ABBV-221
Latest research - ABBV-221
This WikiMD article ABBV-221 is a stub. If you are familiar with the topic ABBV-221, you can help us. Paid editors welcome!
ABBV-221 is part of WikiMD's free ^articles!
^ABBV-221 (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.